CIC-REARRANGED SARCOMA
Clinical trials for CIC-REARRANGED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new CIC-REARRANGED SARCOMA trials appear
Sign up with your email to follow new studies for CIC-REARRANGED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young patients with spreading bone cancer
Disease control OngoingThis trial is testing whether adding two new drugs, irinotecan and regorafenib, to standard chemotherapy works better for young patients with Ewing sarcoma that has spread. It aims to see if this combination helps patients live longer without their cancer returning. The study is …
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope to slow aggressive bone cancers
Disease control OngoingThis study is testing whether a drug called regorafenib can help control the growth of advanced bone sarcomas that have spread to other parts of the body. It involves 163 patients with specific types of bone cancer who have already tried other treatments. Participants are randoml…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC